EDITORIAL
Published on 24 Oct 2022
Editorial: Novel immunotherapies to treat gastrointestinal solid tumor cancers
doi 10.3389/fonc.2022.1043615
- 602 views
- Frontiers in Oncology
- Gastrointestinal Cancers: Gastric and Esophageal Cancers
- Research Topics
- Novel Immunotherapies to Treat Gastrointestinal Solid Tumor Cancers
Novel Immunotherapies to Treat Gastrointestinal Solid Tumor Cancers
13k
Total Downloads
43k
Total Views and Downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
REVIEW
Published on 07 Apr 2022
Neoadjuvant Therapy for Locally Advanced Esophageal Cancers
doi 10.3389/fonc.2022.734581
- 5,409 views
- 7 citations
ORIGINAL RESEARCH
Published on 18 Feb 2022
A Composite Biomarker of Derived Neutrophil–Lymphocyte Ratio and Platelet–Lymphocyte Ratio Correlates With Outcomes in Advanced Gastric Cancer Patients Treated With Anti-PD-1 Antibodies
doi 10.3389/fonc.2021.798415
- 2,233 views
- 9 citations
SYSTEMATIC REVIEW
Published on 21 Dec 2021
Efficacy and Safety of Immune Checkpoint Inhibitor in Advanced Esophageal Squamous Cell Carcinoma: A Meta-Analysis
doi 10.3389/fonc.2021.777686
- 1,843 views
- 6 citations
ORIGINAL RESEARCH
Published on 14 Dec 2021
Neoadjuvant Immunotherapy Combined Chemotherapy Followed by Surgery Versus Surgery Alone for Locally Advanced Esophageal Squamous Cell Carcinoma: A Propensity Score-Matched Study
doi 10.3389/fonc.2021.797426
- 1,813 views
- 12 citations
ORIGINAL RESEARCH
Published on 13 Dec 2021
Loss of Hyaluronan and Proteoglycan Link Protein-1 Induces Tumorigenesis in Colorectal Cancer
doi 10.3389/fonc.2021.754240
- 3,579 views
- 16 citations
ORIGINAL RESEARCH
Published on 03 Dec 2021
Cost-Effectiveness of Adjuvant Immunotherapy With Cytokine-Induced Killer Cell for Hepatocellular Carcinoma Based on a Randomized Controlled Trial and Real-World Data
doi 10.3389/fonc.2021.728740
- 2,578 views
- 6 citations
ORIGINAL RESEARCH
Published on 01 Dec 2021
Cost-Effectiveness Analysis of Camrelizumab vs. Placebo Added to Chemotherapy as First-Line Therapy for Advanced or Metastatic Esophageal Squamous Cell Carcinoma in China
doi 10.3389/fonc.2021.790373
- 2,515 views
- 44 citations
ORIGINAL RESEARCH
Published on 01 Dec 2021
Gastrin Vaccine Alone and in Combination With an Immune Checkpoint Antibody Inhibits Growth and Metastases of Gastric Cancer
doi 10.3389/fonc.2021.788875
- 5,871 views
- 11 citations
ORIGINAL RESEARCH
Published on 25 Nov 2021
Preliminary Efficacy and Safety of Camrelizumab in Combination With XELOX Plus Bevacizumab or Regorafenib in Patients With Metastatic Colorectal Cancer: A Retrospective Study
doi 10.3389/fonc.2021.774445
- 1,878 views
- 9 citations
ORIGINAL RESEARCH
Published on 10 Nov 2021
A Novel Strategy Conjugating PD-L1 Polypeptide With Doxorubicin Alleviates Chemotherapeutic Resistance and Enhances Immune Response in Colon Cancer
doi 10.3389/fonc.2021.737323
- 2,038 views
- 4 citations
ORIGINAL RESEARCH
Published on 06 Oct 2021
Efficacy and Safety of Fruquintinib Plus PD-1 Inhibitors Versus Regorafenib Plus PD-1 Inhibitors in Refractory Microsatellite Stable Metastatic Colorectal Cancer
doi 10.3389/fonc.2021.754881
- 5,270 views
- 24 citations
Published in
Frontiers in Oncology
- Gastrointestinal Cancers: Gastric and Esophageal Cancers
- Gastrointestinal CancersOffline
- Gastrointestinal Cancers: Colorectal Cancer
- Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers
Impact
- 43kTopic views
- 29kArticle views
- 13kArticle downloads